Recommendation of the President – determination of placental growth factor (PlGF) in non-invasive prenatal diagnosis

On 15 August 2024, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 109/2024 on the appropriateness of qualifying the health care service “Determination of placental growth factor (PlGF) in non-invasive prenatal diagnosis” as a guaranteed health program benefit in the Prenatal Testing Program

Publication in Public Information Bulletin (BIP) >>